Aberdeen Group plc Raises Position in Mettler-Toledo International, Inc. $MTD

Aberdeen Group plc grew its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 9.1% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,910 shares of the medical instruments supplier’s stock after purchasing an additional 1,496 shares during the quarter. Aberdeen Group plc owned approximately 0.09% of Mettler-Toledo International worth $21,039,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Greenleaf Trust increased its position in shares of Mettler-Toledo International by 1.2% in the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier’s stock valued at $1,030,000 after acquiring an additional 10 shares during the period. Brooklyn Investment Group increased its position in shares of Mettler-Toledo International by 12.8% in the first quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier’s stock valued at $104,000 after acquiring an additional 10 shares during the period. Sax Wealth Advisors LLC increased its position in shares of Mettler-Toledo International by 2.8% in the second quarter. Sax Wealth Advisors LLC now owns 372 shares of the medical instruments supplier’s stock valued at $437,000 after acquiring an additional 10 shares during the period. Sequoia Financial Advisors LLC increased its position in shares of Mettler-Toledo International by 1.8% in the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier’s stock valued at $740,000 after acquiring an additional 11 shares during the period. Finally, Albion Financial Group UT increased its position in shares of Mettler-Toledo International by 1.5% in the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier’s stock valued at $890,000 after acquiring an additional 11 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Wall Street Analysts Forecast Growth

MTD has been the topic of a number of analyst reports. Citigroup boosted their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research report on Thursday, August 21st. JPMorgan Chase & Co. boosted their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research report on Thursday, October 9th. Robert W. Baird boosted their price target on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research report on Monday, August 4th. Barclays boosted their price target on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a research report on Thursday, October 2nd. Finally, Bank of America boosted their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research report on Monday, September 22nd. Five investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $1,336.50.

Insider Transactions at Mettler-Toledo International

In related news, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the transaction, the director owned 283 shares in the company, valued at $368,154.70. This represents a 78.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Gerry Keller sold 165 shares of the stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the transaction, the insider owned 94 shares in the company, valued at approximately $123,012.16. This trade represents a 63.71% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,827 shares of company stock worth $2,371,208. Corporate insiders own 0.77% of the company’s stock.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD opened at $1,289.13 on Tuesday. The firm’s 50 day moving average price is $1,280.14 and its 200-day moving average price is $1,190.80. The company has a market cap of $26.56 billion, a PE ratio of 32.64, a P/E/G ratio of 3.82 and a beta of 1.37. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,486.76.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.58 by $0.51. The firm had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business’s revenue was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.